Greenhill LL, Pliszka S, Dulcan MK et al. (2002), Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 41(2 suppl):26S-49S [see comments].
Henggeler SW (2004), Decreasing effect sizes for effectiveness studies-implications for the transport of evidence-based treatments: comment on Curtis, Ronan, and Borduin (2004). J Fam Psychol 18(3):420-423 [comment].
Henggeler SW, Clingempeel WG, Brondino MJ, Pickrel SG (2002), Four-year follow-up of multisystemic therapy with substance-abusing and substance-dependent juvenile offenders. J Am Acad Child Adolesc Psychiatry 41(7):868-874.
Henggeler SW, Rowland MD, Halliday-Boykins C et al. (2003), One-year follow-up of multisystemic therapy as an alternative to the hospitalization of youths in psychiatric crisis. J Am Acad Child Adolesc Psychiatry 42(5):543-551.
Kazdin AE (2000), Treatments for aggressive and antisocial children. Child Adolesc Psychiatr Clin N Am 9(4):841-858.
Keller MB, Ryan ND, Strober M et al. (2001), Efficacy of paroxetine(Drug information on paroxetine) in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 40(7):762-772 [see comments].
March J, Silva S, Petrycki S et al. (2004), Fluoxetine(Drug information on fluoxetine), cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 292(7):807-820 [see comments].
McClellan J (2005), Commentary: treatment guidelines for child and adolescent bipolar disorder. J Am Acad Child Adolesc Psychiatry 44(3):236-239 [comment].